Mulkey, F., Theoret, M. R., Keegan, P., Pazdur, R., & Sridhara, R. (2020). Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: Pooled FDA analysis. J Immunother Cancer.

Mulkey, Flora, Marc R. Theoret, Patricia Keegan, Richard Pazdur, e Rajeshwari Sridhara. "Comparison of IRECIST Versus RECIST V.1.1 in Patients Treated With an Anti-PD-1 or PD-L1 Antibody: Pooled FDA Analysis." J Immunother Cancer 2020.

Mulkey, Flora, et al. "Comparison of IRECIST Versus RECIST V.1.1 in Patients Treated With an Anti-PD-1 or PD-L1 Antibody: Pooled FDA Analysis." J Immunother Cancer 2020.